We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$9.86B
AUM Growth
-$803M
(-7.5%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
2.79%
Top 10 Holdings %
Top 10 Hldgs %
30.57%
Holding
177
New
20
Increased
25
Reduced
25
Closed
19
Top Buys
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$123M |
| 2 |
Neuropace
NPCE
|
+$93.1M |
| 3 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
+$77.8M |
| 4 |
Janux Therapeutics
JANX
|
+$77.2M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$74.2M |
Top Sells
| 1 |
Haemonetics
HAE
|
+$94.6M |
| 2 |
AbCellera Biologics
ABCL
|
+$54.5M |
| 3 |
ADVM
Adverum Biotechnologies
ADVM
|
+$54.2M |
| 4 |
Molina Healthcare
MOH
|
+$38M |
| 5 |
PAND
Pandion Therapeutics Inc. Common Stock
PAND
|
+$31.7M |
Sector Composition
| 1 | Healthcare | 95.36% |
| 2 | Technology | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
| $498M | 5.05% |
6,044,266
-142,041
| -2% | -$10.8M |
|
2
Bristol-Myers Squibb
BMY
$120B
| $302M | 3.06% |
4,515,400
| – | – |
|
3
Edgewise Therapeutics
EWTX
$4.25B
| $297M | 3.02% |
13,944,680
| – | – |
|
4
Boston Scientific
BSX
$64.4B
| $296M | 3% |
6,920,600
| – | – |
|
5
Merck
MRK
$305B
| $290M | 2.94% |
3,732,400
-179,155
| -5% | -$13.3M |
|
6
Prelude Therapeutics
PRLD
$348M
| $287M | 2.91% |
10,039,691
| – | – |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $274M | 2.77% |
2,922,155
-222,200
| -7% | -$20.4M |
|
8
ARS Pharmaceuticals
SPRY
$749M
| $270M | 2.74% |
8,740,887
| – | – |
|
9
PMV Pharmaceuticals
PMVP
$77.3M
| $250M | 2.54% |
7,330,423
| – | – |
|
10
Natera
NTRA
$39.3B
| $234M | 2.37% |
2,057,800
-138,100
| -6% | -$14.1M |
|
11
Vertex Pharmaceuticals
VRTX
$120B
| $215M | 2.18% |
1,065,400
-70,500
| -6% | -$14.7M |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $204M | 2.07% |
1,264,200
+43,000
| +4% | +$6.9M |
|
|
TPTX
13
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $184M | 1.87% |
2,361,327
| – | – |
|
14
Iovance Biotherapeutics
IOVA
$1.74B
| $173M | 1.75% |
6,645,100
| – | – |
|
15
Arcutis Biotherapeutics
ARQT
$3.45B
| $166M | 1.68% |
6,073,850
| – | – |
|
16
UnitedHealth
UNH
$382B
| $156M | 1.58% |
389,700
-13,300
| -3% | -$5.3M |
|
17
Guardant Health
GH
$21.6B
| $152M | 1.55% |
1,227,400
+250,000
| +26% | +$33.6M |
|
18
Humana
HUM
$48.4B
| $148M | 1.5% |
335,000
+21,400
| +7% | +$9.35M |
|
|
19
AbCellera Biologics
ABCL
$2.09B
| $137M | 1.39% |
6,223,019
-1,977,749
| -24% | -$54.5M |
|
20
AbbVie
ABBV
$436B
| $132M | 1.33% |
1,167,500
-45,700
| -4% | -$5.15M |
|
21
Intuitive Surgical
ISRG
$138B
| $128M | 1.3% |
418,800
| – | – |
|
22
Elevance Health
ELV
$83.5B
| $128M | 1.3% |
335,700
+49,100
| +17% | +$18.8M |
|
23
DexCom
DXCM
$28.9B
| $127M | 1.29% |
1,189,600
| – | – |
|
|
24
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $127M | 1.28% |
+935,700
| New | +$123M |
|
|
DCPH
25
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $121M | 1.22% |
3,297,301
+1,916,401
| +139% | +$74.2M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM